BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2007
View Archived Issues
AstraZeneca identifies a novel class of small molecule UMP kinase inhibitors
Read More
Odanacatib's preclinical profile reported by Merck & Co.
Read More
Novexel's NXL-101 and NXL-104 evaluated in healthy volunteers
Read More
MK-0429 activity seen in animals and humans with bone metastases
Read More
Combination of CAPOX-B and cetuximab feasible in colorectal cancer
Read More
Studies provide data on S-013420 characteristics in vitro and in pneumonia patients
Read More
VIA receives financial support for ACS substudy of VIA-2291
Read More
First patient dosed in phase III trial of AGI-003 for IBS-D
Read More
Orexo adds two new projects to its development pipeline
Read More
FDA special protocol assessment assigned to atacicept pivotal trial
Read More
New renin inhibitor SPP-676 begins phase I clinical trials
Read More
Two phase II clinical trials launched for GFT-505
Read More
Positive phase II results reported for Lu-AA-21004 in major depression
Read More
Roche files a clinical trial application for Genmab antibody
Read More
Long-acting, nonopiate analgesic drug enters THA trial
Read More
Post-infarct cardiac healing of Corgentin to be evaluated in NIH trial
Read More
New agreement on development and commercialization of THR-174
Read More
Novel treatment options for obesity described in recent Servier and Pharmacopeia patents
Read More
New agents for treating gastrointestinal disorders reported in recent patents
Read More
Four phase I/II clinical trials commence for AEG-35156
Read More
Dosing begins in phase III registration studies for clevudine
Read More
Acusphere progresses toward NDA filing for Imagify
Read More
Enrollment commences for phase I 18F-AV-133 proof-of-concept study
Read More
MacroChem acquires rights to pexiganan
Read More
Ortho-Clinical Diagnostics introduces improved sensitivity troponin I assay
Read More
Phase I results reported for rabies antibody cocktail
Read More
New anticancer agents reported in recent patents
Read More